INCR
InterCure Ltd. [INCR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
INCR Stock Summary
Top 10 Correlated ETFs
INCR
Top 10 Correlated Stocks
INCR
In the News
INCR Financial details
Company Rating
-
Market Cap
107.55M
Income
17.5M
Revenue
414.79M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
370
Optionable
No
Shortable
Yes
Earnings
20 May 2024
P/E
12.81
Forward P/E
-
PEG
0.88
P/S
0.58
P/B
0.44
P/C
-
P/FCF
-16.17
Quick Ratio
1.14
Current Ratio
1.9
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.39
EPS next Y
-
EPS next Q
-
EPS this Y
518.75%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-3.52%
EPS Q/Q
5138.1%
-
-
-
-
SMA20
-
SMA50
400%
SMA100
400%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
3%
ROC
0.04%
Gross Margin
34%
Oper. Margin
6%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.99-2.92
52W High
-
52W Low
-
RSI
54
Rel Volume
-
Avg Volume
94.07K
Volume
3
Perf Week
-0.8%
Perf Month
-9.52%
Perf Quarter
588.07%
Perf Half Y
358.77%
-
-
-
-
Beta
0.24
-
-
Volatility
0.14%, 0.14%
Prev Close
3.98%
Price
5.23
Change
2.55%
Company Profile
- Volume Average 94.07K
- Market Capitalization 107.55M
- Employee 370
- CEO Mr. Alexander Rabinovich
- Headquarters Herzliya,IL
- IPO Date 2019-01-28
-
Website
https://www.intercure.co 
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
